Cat#:Y04702
Name:Y04702 Recombinant Human VEGF165(His Tag）
Species:Human
Specification:10μg/50μg/1mg
Purity:≥95%
Endotoxin: ≤10 EU/mg
Expression System:CHO
Current location: Home > Products > Cell Culture Proteins(GMP Grade) > GFs > VEGFs > Y04702 Recombinant Human VEGF165(His Tag）
Y04702 Recombinant Human VEGF165(His Tag）
Product Brochure
Online Consultation
Related applications
Product Details Cat. No.
Y04702
Purity
≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining)
Endotoxin
≤10 EU/mg by the LAL method
Bioactivity
Measured in a cell proliferation assay using HUVEC human umbilic vein endothelial cells. The ED50 for this effect is 0.2-10 ng/mL.
Accession
P15692
Alternative Names
20 kDa
Expression Region
Ala 27-Arg 191, with a C-terminal 6-His tag
Tag Info
Tag free
Formulation
Lyophilized
Buffer
PBS,5% mannitol and 0.01% Tween 80, pH7.4
Size
10μg/vail 50μg/vail 1mg/vail
Lead Time
Products are in stock,but custom products may require further consultation
Reconstitution
It is recommended to redissolve in sterile deionized water.
Shipping
The product is shipped with blue ice
Storage & Stability
36 months at 2°C to 8°C in lyophilized state
6 months at -20°C to -80°C under sterile conditions after reconstitution
7-10 days at 2°C to 8°C under sterile conditions after reconstitution
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
SDS-PAGE
Recombinant Human VEGF165 (His tag) (Cat. No. Y04702) SDS-PAGE under reducing (R) & Non-reducing conditions. The gel was stained with Y04702 SDS-PAGE.
Bioactivity
Recombinant Human VEGF165 (His tag) (Cat. No. Y04702) stimulates proliferation of HUVEC human umbilic vein endothelial cells. The ED50 for this effect is 0.2-10 ng/mL. Y04702 was higher than other competing products.
Jiangsu East-Mab Bio：Building 13 and 17, 888 Zhujiang Road, Nantong, Jiangsu 226499 , China
Suzhou East-Mab Bio：Floor 5 & 6, Building 1, 168 Majian Road, Suzhou, Jiangsu 215129, China
East-Mab Bio
Quality Management System
Quality Management System
